George Hill
Stock Analyst at Deutsche Bank
(4.60)
# 941
Out of 5,088 analysts
628
Total ratings
54.8%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Reiterated: Hold | $129 → $163 | $198.95 | -18.07% | 25 | Oct 26, 2026 | |
| MCK McKesson | Reiterated: Buy | $875 → $913 | $980.88 | -6.92% | 68 | Oct 6, 2026 | |
| CLOV Clover Health Investments | Initiated Coverage: Buy | $6 | $4.58 | +31.00% | 1 | Sep 11, 2026 | |
| HQY HealthEquity | Rated: Buy | $128 → $142 | $101.36 | +40.09% | 25 | Aug 31, 2026 | |
| CAH Cardinal Health | Reiterated: Hold | $261 | $251.09 | +3.95% | 48 | Aug 13, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | $3 → $1 | $1.12 | -10.71% | 14 | Aug 12, 2026 | |
| HIMS Hims & Hers Health | Rated: Hold | $25 → $26 | $29.67 | -12.37% | 16 | Aug 11, 2026 | |
| EHTH eHealth | Reiterated: Hold | $3 → $2 | $0.5206 | +284.17% | 24 | Aug 6, 2026 | |
| UNH UnitedHealth Group | Reiterated: Hold | n/a | $410.91 | - | 38 | Aug 3, 2026 | |
| CI The Cigna Group | Reiterated: Hold | $302 → $305 | $298.41 | +2.21% | 31 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $37 → $39 | $28.21 | +38.25% | 5 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $441 → $436 | $417.56 | +4.42% | 38 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $39 → $80 | $68.62 | +16.58% | 23 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $332 → $498 | $422.02 | +18.00% | 20 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $33 → $49 | $85.94 | -42.98% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $90.33 | +1.85% | 53 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $12 → $11 | $8.73 | +26.00% | 41 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $3 | $3.54 | -15.25% | 18 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $322 → $371 | $330.53 | +12.24% | 38 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $295 → $210 | $215.48 | n/a | 11 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $5 | $4.75 | n/a | 32 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $175 | $290.79 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 → $250 | $275.06 | n/a | 20 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $409 → $350 | $376.10 | n/a | 16 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $36.41 | n/a | 1 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $91 | $86.44 | n/a | 1 | Sep 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $125.76 | n/a | 1 | Oct 6, 2011 |
Molina Healthcare
Oct 26, 2026
Reiterated: Hold
Price Target: $129 → $163
Current: $198.95
Upside: -18.07%
McKesson
Oct 6, 2026
Reiterated: Buy
Price Target: $875 → $913
Current: $980.88
Upside: -6.92%
Clover Health Investments
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $4.58
Upside: +31.00%
HealthEquity
Aug 31, 2026
Rated: Buy
Price Target: $128 → $142
Current: $101.36
Upside: +40.09%
Cardinal Health
Aug 13, 2026
Reiterated: Hold
Price Target: $261
Current: $251.09
Upside: +3.95%
Definitive Healthcare
Aug 12, 2026
Reiterated: Hold
Price Target: $3 → $1
Current: $1.12
Upside: -10.71%
Hims & Hers Health
Aug 11, 2026
Rated: Hold
Price Target: $25 → $26
Current: $29.67
Upside: -12.37%
eHealth
Aug 6, 2026
Reiterated: Hold
Price Target: $3 → $2
Current: $0.5206
Upside: +284.17%
UnitedHealth Group
Aug 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $410.91
Upside: -
The Cigna Group
Jul 31, 2026
Reiterated: Hold
Price Target: $302 → $305
Current: $298.41
Upside: +2.21%
Jul 31, 2026
Rated: Buy
Price Target: $37 → $39
Current: $28.21
Upside: +38.25%
Jul 30, 2026
Reiterated: Buy
Price Target: $441 → $436
Current: $417.56
Upside: +4.42%
May 20, 2026
Upgraded: Buy
Price Target: $39 → $80
Current: $68.62
Upside: +16.58%
May 20, 2026
Upgraded: Buy
Price Target: $332 → $498
Current: $422.02
Upside: +18.00%
May 7, 2026
Upgraded: Buy
Price Target: $33 → $49
Current: $85.94
Upside: -42.98%
May 7, 2026
Reiterated: Buy
Price Target: $92
Current: $90.33
Upside: +1.85%
Mar 10, 2026
Upgraded: Buy
Price Target: $12 → $11
Current: $8.73
Upside: +26.00%
Feb 27, 2026
Reiterated: Hold
Price Target: $6 → $3
Current: $3.54
Upside: -15.25%
Nov 7, 2025
Reiterated: Buy
Price Target: $322 → $371
Current: $330.53
Upside: +12.24%
Jul 29, 2025
Reiterated: Buy
Price Target: $295 → $210
Current: $215.48
Upside: n/a
Mar 27, 2025
Reiterated: Hold
Price Target: $10 → $5
Current: $4.75
Upside: n/a
Jun 28, 2024
Reiterated: Hold
Price Target: $175
Current: $290.79
Upside: n/a
Mar 22, 2022
Reiterated: Buy
Price Target: $255 → $250
Current: $275.06
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $409 → $350
Current: $376.10
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: $68
Current: $36.41
Upside: n/a
Sep 19, 2017
Initiated Coverage: Hold
Price Target: $91
Current: $86.44
Upside: n/a
Oct 6, 2011
Upgraded: Buy
Price Target: n/a
Current: $125.76
Upside: n/a